Blue Star Foods to Present at Two Upcoming Investor Conferences
20 mai 2022 08h30 HE
|
Blue Star Foods Corp.
CEO John Keeler to Present and Host Meetings at H.C. Wainwright Global Investment Conference and LD Micro Invitational XII Miami, FL, May 20, 2022 (GLOBE NEWSWIRE) -- Blue Star Foods Corp.,...
Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference
19 mai 2022 08h30 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex...
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
18 mai 2022 08h15 HE
|
ProPhase Labs, Inc.
May 23-26, 2022 (HYBRID CONFERENCE) Garden City, NY, May 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that...
GreenBox POS to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022
18 mai 2022 08h00 HE
|
GreenBox POS
SAN DIEGO, CA, May 18, 2022 (GLOBE NEWSWIRE) -- GreenBox POS (NASDAQ: GBOX) (“GreenBox” or “the Company”), an emerging and rapidly growing fintech company today announced that management will...
Cocrystal Pharma to Present at the H.C. Wainwright Global Investment Conference
18 mai 2022 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., May 18, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, Chief Financial Officer and co-interim Chief Executive Officer, will present a...
mPhase to Present at the H.C. Wainwright Global Investment Conference
17 mai 2022 16h42 HE
|
mPhase Technologies, Inc.
Rockville, MD, May 17, 2022 (GLOBE NEWSWIRE) -- mPhase Technologies, Inc. (OTC Pink: XDSL) (“mPhase” or the “Company”), a technology company developing the mPower EV+ (electric vehicle) charging...
InflaRx to Present at the H.C. Wainwright Global Investment Conference
17 mai 2022 07h30 HE
|
InflaRx N.V.
JENA, Germany, May 17, 2022 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system,...
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
16 mai 2022 07h00 HE
|
ObsEva SA
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company...
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
16 mai 2022 01h00 HE
|
ObsEva SA
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company...
Vyant Bio to Present at the H.C. Wainwright Bioconnect Conference
10 janv. 2022 08h00 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...